EC
KZR

EcoR1 Capital’s Kezar Life Sciences KZR Stock Holding History

EcoR1 Capital’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-58,329
Closed -$4.5M – 41
2019
Q2 		$4.5M Sell
58,329
-27,318
-32% -$4.25M 0.45% 33
2019
Q1 		$15.2M Sell
85,647
-20,355
-19% -$4.01M 1.4% 21
2018
Q4 		$25M Sell
106,002
-22,818
-18% -$5.58M 2.5% 14
2018
Q3 		$27.6M Buy
128,820
+1,600
+1% +$279K 2.48% 11
2018
Q2 		$22M Buy
+127,220
New +$22.2M 2.1% 14

Other funds holding KZR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

EcoR1 Capital's KZR Position: Q3 2019 in Review

EcoR1 Capital sold out of Kezar Life Sciences (KZR) in Q3 2019, closing a stake of 58,329 shares — an estimated $4.5M sold.

EcoR1 Capital first reported a position in KZR in Q2 2018 and held it in 5 quarters. The position peaked at $27.6M in Q3 2018. 54 funds tracked by Wall St. Rank hold KZR as of Q3 2019.

  • EcoR1 Capital reported no remaining Kezar Life Sciences position as of Q3 2019 after selling out during the quarter.
  • EcoR1 Capital sold 58,329 Kezar Life Sciences shares in Q3 2019, an estimated $4.5M.
  • EcoR1 Capital first reported a position in Kezar Life Sciences in Q2 2018 and held it in 5 quarters.
  • EcoR1 Capital's Kezar Life Sciences position peaked at $27.6M in Q3 2018.
  • 54 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2019.

Based on EcoR1 Capital's 13F filing for Q3 2019, filed 14 Nov 2019.